Zu "1020412-43-4" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Gardiquimod
Artikelnummer: TGM-T15371-10mg
Description: Gardiquimod could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells. Gardiquimod is an imidazoquinoline analog and is a TLR7/8 agonist. When used at concentrations below 10 µM, Gardiquimod specifically activates TLR7. Target: TLR, HIV Protease. Smiles:...
| Anwendung: | TLR7 ligand |
| CAS | 1020412-43-4 |
| MW: | 313.4 D |
ab 31,00 €
Gardiquimod
Artikelnummer: Cay18877-5
Gardiquimod is an agonist of human toll-like receptor 7 (TLR7), but not human TLR8, although it activates both porcine TLR7 and TLR8. At 0.5 to 2 µg/ml, it enhances the immunosuppressive activity of T regulatory cells. Gardiquimod is effective as a mucosal adjuvant for Norwalk virus-like particles and inhibits...
| Schlagworte: | 4-amino-2-[(ethylamino)methyl]-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol |
| Anwendung: | TLR7 agonist |
| CAS | 1020412-43-4 |
| MW: | 313.4 D |
ab 66,00 €
Gardiquimod
Artikelnummer: AG-CR1-3583-M005
Synthetic. Immune response modifier. Antiviral and antitumor compound Selective ligand for human or mouse Toll-like receptor 7 (TLR7). Induces the activation of NF-kappaB in HEK 293 cells expressing TLR7 at 0.1µg/ml. 10 times more active than Imiquimod (Prod. No. AG-CR1-3569). At high concentrations (3µg/ml)...
| Schlagworte: | 1-(4-Amino-2-ethylaminomethylimidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol |
| Anwendung: | TLR7 ligand |
| CAS | 1020412-43-4 |
| MW: | 313,4 D |
ab 50,00 €
